Form 4 for WHWK Whitehawk Therapeutics, Inc.
Accepted 2026-05-18 16:03:41 ET · period of report 2026-05-14 · accession 0001995275-26-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-18 16:03 | 2026-05-14 | WHWK | Lennon David James | CEO, Dir | A - Grant | $3.92 | +51.0K | 569.6K | +10% | +$200.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-14 | A | A | 51,021 | $3.92 | 569,643 | D | — | — |